Powder: -20°C for 3 years | In solvent: -80°C for 1 year
RK-0133114, a G9a inhibitor and the R-enantiomer of RK-701, exhibits potent inhibition of G9a with an IC50 value of 3.7 μM. This compound is utilized in research focused on sickle cell disease (SCD) [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 8-10 weeks | $ 1,820.00 | |
50 mg | 8-10 weeks | $ 2,380.00 | |
100 mg | 8-10 weeks | $ 3,100.00 |
Description | RK-0133114, a G9a inhibitor and the R-enantiomer of RK-701, exhibits potent inhibition of G9a with an IC50 value of 3.7 μM. This compound is utilized in research focused on sickle cell disease (SCD) [1]. |
Molecular Weight | 446.54 |
Formula | C26H30N4O3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.